#USA #Miami #Parkinson's Foundation #PD research #Environmental Trigger

A Major Leap in Parkinson's Research Funding

On August 18, 2026, the Parkinson's Foundation revealed an unprecedented investment exceeding $7.5 million across 55 research grants, aimed at accelerating research into Parkinson's Disease (PD). This substantial funding marks a historic milestone and reflects the foundation’s ongoing dedication to advancing innovative studies across various dimensions of PD. With around 10 million individuals globally afflicted by this debilitating neurological disorder, the Foundation is focused on fostering breakthroughs that could lead to new therapies and, ultimately, a cure.

Record Number of Grants Awarded

John Lehr, President and CEO of the Parkinson's Foundation, expressed enthusiasm regarding the record number of grants awarded this year. “Through the tremendous support of our donors, the Foundation continues to demonstrate its unwavering commitment to funding research that can accelerate breakthroughs in therapies for people living with the disease,” he noted.

To respond to the increasing needs of the research community, the Foundation has doubled its Impact Awards, which support researchers who are making essential strides in advancing innovative studies. Furthermore, they have introduced two novel research award categories this year:
1. Momentum Awards: These grants empower exceptional researchers to persist in translational, therapeutically-focused projects stemming from previously awarded Parkinson's Foundation grants.
2. Environmental Trigger Awards: This new category introduces research examining environmental factors interconnected with PD, helping to shape policies aimed at reducing harmful exposures at both state and federal levels.

Groundbreaking Research Underway

One prominent recipient of the Parkinson's Foundation's Environmental Trigger Award is Dr. Ethan Brown, who is undertaking vital research at the University of California, San Francisco. His project aims to establish a clear link between toxicant exposure—such as from pesticides, solvents, metals, and other pollutants—and the onset of PD in humans. Dr. Brown's research focuses on analyzing data from the Child Health and Development Studies (CHDS), a cohort study that enrolled nearly 30,000 parents back in the early 1960s.

These participants contributed invaluable information regarding their habits and home environments, helping researchers examine potential relationships between environmental exposures and developmental effects on their children. As these children ages, particularly reaching around 65 years old—a common age for PD diagnosis—this extensive data set can provide insights into potential exposure patterns during early childhood that may correlate with the later development of PD.

“Identifying early-life risk factors for Parkinson’s could expand our understanding of how the disease develops and open new opportunities for prevention decades before symptoms appear,” stated Dr. Brown. His findings could significantly influence future research aimed at creating earlier and more effective treatments for this complex disorder.

Competitive Selection Process

The grants awarded by the Parkinson's Foundation undergo a rigorous selection process, characterized by a competitive application review led by a panel of scientific experts. This comprises members of the Foundation's Scientific Advisory Board alongside trained research advocates. Besides the Environmental Trigger and Momentum Awards, additional award categories include independent investigator awards, fellowships, and early career awards.

James Beck, PhD, Chief Scientific Officer at the Parkinson's Foundation, emphasized the necessity for robust scientific effort and substantial financial backing to effectively tackle a complex disease like PD. “The Foundation is excited to work with these exceptional scientists who are helping make even greater strides in the fight against PD,” he remarked.

Conclusion

The Parkinson’s Foundation's recent investment is a potent reminder of the critical importance of research and innovation in combating diseases like PD. Their commitment reflects a thorough dedication towards not only improving the lives of those currently affected by the disease but also towards a future where effective treatments—and possibly a cure—may be found. For more detailed information about the 2026 research grant recipients and ongoing opportunities, please visit Parkinson.org/ResearchGrants.

About the Parkinson's Foundation

The Parkinson's Foundation has dedicated itself to enhancing the quality of life for people living with Parkinson’s disease while relentlessly working towards research that brings the possibility of a cure closer to reality. Since its inception in 1957, the Foundation has invested over $513 million into research and clinical care focused on PD.